Marcos Timón

1.2k total citations
33 papers, 832 citations indexed

About

Marcos Timón is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Marcos Timón has authored 33 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Marcos Timón's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (8 papers) and Biomedical Ethics and Regulation (7 papers). Marcos Timón is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (8 papers) and Biomedical Ethics and Regulation (7 papers). Marcos Timón collaborates with scholars based in Spain, Germany and United Kingdom. Marcos Timón's co-authors include José R. Regueiro, Alfredo Corell, Paloma Pérez‐Aciego, José Manuel Martín‐Villa, Antonio Arnaiz-Villena, Laura López-Fuertes, Olga Francino, Jordi Alberola, A. Rodríguez and Antonio Arnaiz‐Villena and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and European Journal of Immunology.

In The Last Decade

Marcos Timón

31 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcos Timón Spain 17 475 232 205 158 102 33 832
Floriane Auderset Switzerland 16 586 1.2× 171 0.7× 245 1.2× 182 1.2× 47 0.5× 20 931
Bruno Canque France 17 802 1.7× 321 1.4× 128 0.6× 217 1.4× 65 0.6× 34 1.4k
Jenna J. Guthmiller United States 16 633 1.3× 212 0.9× 249 1.2× 216 1.4× 54 0.5× 32 963
Nyamekye Obeng-Adjei United States 12 622 1.3× 300 1.3× 123 0.6× 125 0.8× 35 0.3× 16 879
Sara Calattini France 24 502 1.1× 369 1.6× 470 2.3× 121 0.8× 77 0.8× 41 1.4k
Matthias Regner Australia 19 551 1.2× 224 1.0× 312 1.5× 251 1.6× 101 1.0× 38 1.1k
Douglas H. Gebhard United States 14 308 0.6× 170 0.7× 360 1.8× 100 0.6× 195 1.9× 21 939
Nina Hambruch Germany 20 260 0.5× 153 0.7× 99 0.5× 167 1.1× 70 0.7× 34 767
J. P. Magnol France 18 308 0.6× 114 0.5× 137 0.7× 137 0.9× 432 4.2× 37 1.3k
S. A. Ellis United Kingdom 21 1.2k 2.5× 303 1.3× 140 0.7× 186 1.2× 120 1.2× 39 1.5k

Countries citing papers authored by Marcos Timón

Since Specialization
Citations

This map shows the geographic impact of Marcos Timón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Timón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Timón more than expected).

Fields of papers citing papers by Marcos Timón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Timón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Timón. The network helps show where Marcos Timón may publish in the future.

Co-authorship network of co-authors of Marcos Timón

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos Timón. A scholar is included among the top collaborators of Marcos Timón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos Timón. Marcos Timón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felipe, Pablo de, Raquel Martín-Folgar, Jorge Contreras, et al.. (2025). The Coming of Age of Gene Therapy for the Treatment of Human Diseases: A Regulatory Perspective. Human Gene Therapy. 36(17-18). 1103–1117.
2.
Schuessler‐Lenz, Martina, Carla Herberts, Ilona Reischl, et al.. (2023). Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe. Advances in experimental medicine and biology. 1430. 1–21. 4 indexed citations
3.
Timón, Marcos, et al.. (2023). Clinical Trials on Advanced Therapy Investigational Medicinal Products in Spain (2004–2022): Experience and Challenges for the Future. Advances in experimental medicine and biology. 1430. 23–39. 1 indexed citations
4.
5.
Sánchez, Armand, Laura Altet, Jordi Alberola, et al.. (2008). Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs. Veterinary Immunology and Immunopathology. 125(1-2). 168–175. 19 indexed citations
6.
Rodríguez, A., Ana Ojeda, Laura López-Fuertes, et al.. (2007). Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge. Vaccine. 25(46). 7962–7971. 51 indexed citations
7.
Rodríguez, A., Ana Ojeda, Laura López-Fuertes, et al.. (2006). A long term experimental study of canine visceral leishmaniasis. International Journal for Parasitology. 37(6). 683–693. 68 indexed citations
8.
López-Fuertes, Laura, Eva Pérez-Jiménez, Antonio J. Vila‐Coro, et al.. (2002). DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine. 21(3-4). 247–257. 58 indexed citations
9.
10.
11.
Walker, A. M., et al.. (1998). A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. European Journal of Immunology. 28(1). 22–29. 37 indexed citations
12.
Timón, Marcos, Greg Elgar, Sonoko Habu, Katsuzumi Okumura, & Peter C. L. Beverley. (1997). Molecular cloning of major histocompatibility complex class I cDNAs from the pufferfish Fugu rubripes. Immunogenetics. 47(2). 170–173. 17 indexed citations
13.
Martín‐Villa, José Manuel, Narcisa Martı́nez-Quiles, Alfredo Corell, et al.. (1996). Diploid Expression of Human Leukocyte Antigen Class I and Class II Molecules on Spermatozoa and their Cyclic Inverse Correlation with Inhibin Concentration1. Biology of Reproduction. 55(3). 620–629. 31 indexed citations
14.
Rodríguez‐Gallego, Carlos, Alfredo Corell, Marcos Timón, et al.. (1996). Herpes virus saimiri transformation of T cells in CD3γ immunodeficiency: phenotypic and functional characterization. Journal of Immunological Methods. 198(2). 177–186. 19 indexed citations
15.
Rodríguez‐Gallego, Carlos, et al.. (1995). Diseases involving the T-cell receptor/CD3 complex. Critical Reviews in Oncology/Hematology. 19(2). 131–147. 3 indexed citations
16.
Góngora, Rafael, Alfredo Corell, José R. Regueiro, et al.. (1994). Peripheral blood reduction of memory (CD29+, CD45RO+, and “Bright” CD2+ and LFA-1+) T lymphocytes in Papillon-Lefèvre syndrome. Human Immunology. 41(3). 185–192. 12 indexed citations
17.
Timón, Marcos, et al.. (1993). Selective disbalances of peripheral blood T lymphocyte subsets in human CD3γ deficiency. European Journal of Immunology. 23(7). 1440–1444. 23 indexed citations
18.
Arnaiz-Villena, Antonio, Marcos Timón, Alfredo Corell, et al.. (1992). Primary Immunodeficiency Caused by Mutations in the Gene Encoding the CD3-γ Subunit of the T-Lymphocyte Receptor. New England Journal of Medicine. 327(8). 529–533. 172 indexed citations
19.
Arnaiz‐Villena, Antonio, Marcos Timón, Carlos Rodríguez‐Gallego, et al.. (1992). Human T-cell activation deficiencies. Immunology Today. 13(7). 259–265. 32 indexed citations
20.
Pérez‐Aciego, Paloma, Balbino Alarcón, Antonio Arnaiz‐Villena, et al.. (1991). Expression and function of a variant T cell receptor complex lacking CD3-gamma.. The Journal of Experimental Medicine. 174(2). 319–326. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Floriane Auderset Breakdown of academic impact, for papers by Bruno Canque Breakdown of academic impact, for papers by Jenna J. Guthmiller Breakdown of academic impact, for papers by Nyamekye Obeng-Adjei Breakdown of academic impact, for papers by Sara Calattini Breakdown of academic impact, for papers by Matthias Regner Breakdown of academic impact, for papers by Douglas H. Gebhard Breakdown of academic impact, for papers by Nina Hambruch Breakdown of academic impact, for papers by J. P. Magnol Breakdown of academic impact, for papers by S. A. Ellis
Rankless by CCL
2026